Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Mochida ReFeel til digitale nervebeskadigelser

10. november 2026 opdateret af: OrthoCarolina Research Institute, Inc.

Undersøgerledet Observationsstudie til Klinisk Forskning, der Vurderer Virkningen af ReFeel til Digitale Nervebeskadigelser.

This is an Investigator Led single-center, Prospective and Observational, Clinical Research Project. The specific aim of this study is to test/observe the safety and effectiveness of the ReFeel Device for Digital nerve injury in improving recovery time and outcomes. The primary objective of this study is to monitor clinical and surgical procedural outcomes for the use of ReFeel device.

Studieoversigt

Status

Tilmelding efter invitation

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

ReFeel is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.

ReFeel is a device used in applications for patients with peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.

Despite this common injury there is continued debate on the best treatment algorithm for digital nerve injuries. Digital nerve repair is usually not an option as the field of injury is too large for direct repair. Both conduits and nerve allograft have been used with varying success. Nerve conduits have traditionally been used for gaps less than 2 cm, with allograft for larger gaps.

ReFeel has received 510(k) clearance for a new alginate-based nerve cuff. We propose to conduct an Investigator-led Observational Clinical Research of ReFeel for patients treated with alginate nerve cuff to assess the clinical function following reconstruction.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

5

Fase

  • Fase 4

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • North Carolina
      • Charlotte, North Carolina, Forenede Stater, 28207
        • OrthoCarolina Research Institute

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 69 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Age 18-69 years
  • Digital nerve injury in at least one digit requiring repair with a gap of 1-25mm
  • Able to provide tension free end to end nerve coaptation
  • Have uninjured contralateral or adjacent digit that is suitable to serve as a referenced digit for baseline functional assessments.
  • Willing to comply with follow up for visits up to 12 months.

Exclusion Criteria:

  • Estimated distance of recovery greater than 150 mm (from proximal site of to the tip of the digit)
  • Injury distal to distal interphalangeal joint
  • Extensive soft tissue injury that will impair recovery assessment
  • Incomplete nerve transections
  • Injury requiring replantation of the target digit
  • Injuries to the affected nerve proximal to the superficial arch
  • Nerve injuries > 24 weeks after initial injury
  • End to side nerve repair
  • Injuries with vascular damage resulting in inadequate perfusion despite repair
  • Subjects with type 1 diabetes or type 2 diabetes requiring regular insulin therapy
  • Subjects who are undergoing or expected to undergo treatment with chemotherapy, radiation therapy, or other know treatment that affects the growth of neural and/or vascular system
  • History of neuropathy, diabetic neuropathy, or another known neuropathy
  • Excepted use of medication during the study that is known to impact nerve regeneration or cause peripheral neuropathy such as immunosuppressant's and Chemotherapeutic
  • History of chronic ischemic condition of the upper extremity.
  • Workers Compensation

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Andet: ReFeel device

Subjects who enroll in this study will receive ReFeel device for Digital nerve injury

ReFeel is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.

ReFeel is a device used in applications for patients with peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from Baseline in Static two-point discrimination
Tidsramme: Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months

Presented in millimetres and in ASSH designation (less than 6 mm 'normal', 6-10 mm 'fair', and 11 to 15 mm 'poor')

Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Visual Analog Scale (VAS)
Tidsramme: Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months

Pain Score (1-10, 1 being the best and 10 being the worst pain)

Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
Water emersion testing
Tidsramme: 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months

Recommend patients submerge injured hand into water until other digits wrinkle. Report weekly if finger wrinkles like non-injured digits.

2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
Physician Satisfaction Score
Tidsramme: Operative

Scale 0-5, with 0 being very difficult and 5 being very Easy the best score

Operative
How many nerves were repaired with the provided graft sheet?
Tidsramme: Operative

How many nerves were repaired with the provided graft sheet?

Operative
Change in Range of Motion (ROM)
Tidsramme: Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months

Change in Range of Motion (ROM) of the injured digit, measured in degrees, from baseline

Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Glenn Gaston, MD, OrthoCarolina Research Institute

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. november 2026

Primær færdiggørelse (Anslået)

31. december 2027

Studieafslutning (Anslået)

31. december 2028

Datoer for studieregistrering

Først indsendt

30. marts 2026

Først indsendt, der opfyldte QC-kriterier

8. april 2026

Først opslået (Faktiske)

13. april 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 9220 (ReFeel - 0001)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

IPD-planbeskrivelse

To be determined at a later date.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .